2025年3月10日，Belite Bio (NASDAQ: BLTE)在Leerink 2025年全球医疗大会上发表演讲，首席科学官Nathan Mata分享了其药物TINlarabant在治疗Stargardt病和地理性萎缩 (GA)方面的第二期临床试验成果，同时也讨论了监管挑战和未来市场准入计划。

After hours: March 11 at 4:36:55 PM EDT Loading Chart for BLTE ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Senior Managing Partner of Belite Capital Gerson Gibbs joined the DMV Zone. PostedMarch 13, 2025 9:47am EDT ...

After hours: March 12 at 4:05:08 PM EDT Loading Chart for OCS ...

Welcome to the September edition of Changing Faces. September ushered in a wave of significant appointments across the pharmaceutical and biotechnology industries, with companies from big pharma ...